Sort
46,585 grants matching “heart failure”
Cardiac Myosin Binding Protein-C: Structure, Function, and Regulation
$2,181,684David M Warshaw · University Of Vermont & St Agric College · P01 · FY2010 · HL
CARDIAC RHYTHM &ARRHYTHMIAS IN NEONATE, YOUNG &ADULT
$2,180,006Columbia University Health Sciences · P01 · FY2001 · HL
Multiethnic Study of Breast Arterial Calcium Gradation and CVD
$2,179,612Carlos Iribarren · Kaiser Foundation Research Institute · R01 · FY2012 · HL
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY
$2,178,934Kirk U Knowlton · University Of California, San Diego · P01 · FY2006 · HL
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
$2,175,434Rebecca Gersnoviez Clifton · George Washington University · U24 · FY2020 · HL
Molecular Pathways for Hypertrophy and Cardiomyopathy
$2,175,021Kirk U Knowlton · University Of California, San Diego · P01 · FY2011 · HL
Molecular Pathways for Hypertrophy and Cardiomyopathy
$2,175,021Kirk U Knowlton · University Of California, San Diego · P01 · FY2007 · HL
Molecular Pathways for Hypertrophy and Cardiomyopathy
$2,175,021Kirk U Knowlton · University Of California, San Diego · P01 · FY2010 · HL
Molecular Pathways for Hypertrophy and Cardiomyopathy
$2,175,021Kirk U Knowlton · University Of California, San Diego · P01 · FY2009 · HL
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,174,014Hanno Steen · Boston Children'S Hospital · U19 · FY2020 · AI
COVID-19 Immunophenotyping Proteomics and Metabolomics Core (PMC)
$2,174,014Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
$2,173,410James Brugarolas · Ut Southwestern Medical Center · P50 · FY2022 · CA
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
$2,173,408James Brugarolas · Ut Southwestern Medical Center · P50 · FY2023 · CA
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
$2,172,318Jennifer E Van Eyk · Johns Hopkins University · N01 · FY2011 · HL
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY
$2,171,127University Of California San Diego · P01 · FY2005 · HL
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
$2,170,027Michael J Boeckh · Fred Hutchinson Cancer Center · UH3 · FY2024 · HL
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
$2,168,405John L Thompson · Columbia University Health Sciences · U01 · FY2008 · NS
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure
$2,168,372Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · P50 · FY2012 · HL
Systolic Blood Pressure Intervention Trial (SPRINT)
$2,167,624Suzanne Oparil · University Of Alabama At Birmingham · N01 · FY2016 · HL
Integrative Neurobiology of Cardiovascular Regulation
$2,167,530University Of Iowa · P01 · FY2003 · HL
2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women
$2,166,106Elizabeth A Thom · George Washington University · U24 · FY2019 · HL
Proteogenomics for Organ Transplantation: Prediction, Diagnosis, Intervention
$2,165,183Michael Abecassis · Northwestern University At Chicago · U01 · FY2010 · AI
GENETIC APPROACHES TO EARLY CARDIAC DEVELOPMENT
$2,163,566Robert Schwartz · Texas A&M University Health Science Ctr · P01 · FY2006 · HL
Genetics and Treatment of Heart Failure in the Young
$2,163,330Loren J Field · Indiana University Indianapolis · P01 · FY2011 · HL
The ISCHEMIA-CKD Trial-CCC-Lead Application
$2,162,294Sripal Bangalore · New York University School Of Medicine · U01 · FY2014 · HL